Kabra Drugs informs about annual secretarial compliance report

05 May 2022 Evaluate

Kabra Drugs has informed that Annual Secretarial Compliance Report under regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018 read with BSE Circular dated 9th May, 2019 is not applicable to the Company. Further clarified that the Company is claiming exemption under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 as Corporate Governance provision shall not apply to listed entities having paid up Equity Share Capital not exceeding Rupees 10 Crores and net worth not exceeding Rupees 25 Crores, as on the day of previous financial year. Hence, the Company is not required to submit Annual Secretarial Compliance Report as the Company is exempted under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Kabra Drugs Share Price

9.14 0.00 (0.00%)
28-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.